Search
for
Sort by
Research 61–90 of 1000+
- A case of secondary diabetes mellitus associated with chronic arsenic toxicity
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Dermatological manifestations associated with pregnancy
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Cutaneous manifestations of methylmalonic and propionic acidaemia: a description based on 38 cases
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Toxicities From Transplantation-Related Medications
- Analysis of pediatric dermatology inpatient consultations in a pediatric teaching hospital
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Rosacea and Rosacea-like Demodicldosis
- Evaluation of the safety and efficacy of a fractional picosecond 1064 nm laser for post‐acne erythema in adult Chinese patients
- Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Topical imiquimod—Be aware of the unexpected
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- COVID-19感染症でみられる皮膚病変
- Cutaneous Manifestations of COVID-19: A Brief Review of a Possible Diagnostic Tool
- Self-Assessment
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Zdravstvena njega bolesnica sa kožnim bolestima u trudnoći
- Hypersensitivity Diseases